BH.IMMUN&BIO Fact Sheet, BH.IMMUN&BIO Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BH.IMMUN&BIO Fact Sheet    (BHIB)


LIVE NOW: Join Our Urgent Broadcast on India's Revival with Tanushree Banerjee


Here is the latest financial fact sheet of BH.IMMUN&BIO. For more details, see the BH.IMMUN&BIO quarterly results and BH.IMMUN&BIO share price and chart. For a sector overview, read our pharmaceuticals sector report.

BH.IMMUN&BIO Price History

Price Rs 55.7
Mkt Cap Rs m 2,403
Vol '000 58.0
P/E X -52.0
P/CF X -24.1
EPS (TTM) Rs -1.1
% ch % 0.7
No. of shares m 43.18
% ch week % -2.7
% ch 1-mth % 29.3
% ch 12-mth % 82.2
52 week H/L Rs 94.5/21.3
(As on Sep 24, 2021 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BH.IMMUN&BIO Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BH.IMMUN&BIO EQUITY SHARE DATA
High Rs4326392715 
Low Rs17171875 
Sales per share (Unadj.) Rs29.728.88.119.415.5 
Earnings per share (Unadj.) Rs-1.41.5-1.0-1.3-2.4 
Diluted earnings per shareRs-1.41.5-1.0-1.3-2.4 
Cash flow per share (Unadj.) Rs-1.31.6-0.9-1.3-2.3 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs8.19.78.77.14.7 
Adj. book value per shareRs8.19.78.77.14.7 
Shares outstanding (eoy) m43.1843.1843.1843.1843.18 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.00.73.50.90.7 
Avg P/E ratio x-21.114.3-28.9-12.8-4.3 
P/CF ratio (eoy) x-23.613.1-32.0-13.4-4.4 
Price / Book Value ratio x3.72.23.32.42.1 
Dividend payout %00000 
Avg Mkt Cap Rs m1,3119291,230739436 
No. of employees `000NANANANANA 
Total wages/salary Rs m10010210398114 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BH.IMMUN&BIO INCOME DATA
Net Sales Rs m1,2801,242348836668 
Other income Rs m1412144212 
Total revenues Rs m1,2941,254362879680 
Gross profit Rs m-40128-79-93-104 
Depreciation Rs m66432 
Interest Rs m5742102048 
Profit before tax Rs m-9092-80-74-142 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-2727-37-16-40 
Profit after tax Rs m-6265-43-58-102 
Gross profit margin %-3.110.3-22.8-11.1-15.6 
Effective tax rate %30.729.446.521.428.1 
Net profit margin %-4.85.2-12.2-6.9-15.3 
BH.IMMUN&BIO BALANCE SHEET DATA
Current assets Rs m598468382987930 
Current liabilities Rs m2991411258851,007 
Net working cap to sales %23.426.373.812.3-11.5 
Current ratio x2.03.33.01.10.9 
Inventory Days Days17224983 
Debtors Days Days371916731896 
Net fixed assets Rs m617973162198 
Share capital Rs m432432432432432 
"Free" reserves Rs m-81-14-57-125-227 
Net worth Rs m351418375307205 
Long term debt Rs m00000 
Total assets Rs m6595474551,1501,128 
Interest coverage x-0.63.2-6.9-2.7-2.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.92.30.80.70.6 
Return on assets %-0.819.6-7.2-3.3-4.8 
Return on equity %-17.715.6-11.4-18.9-49.9 
Return on capital %-9.332.2-18.5-17.5-46.2 
Exports to sales %00000 
Imports to sales %104.263.980.5105.2142.3 
Exports (fob) Rs m00000 
Imports (cif) Rs m1,334794280880951 
Fx inflow Rs m000331 
Fx outflow Rs m1,334794280880951 
Net fx Rs m-1,334-794-280-848-950 
BH.IMMUN&BIO CASH FLOW
From Operations Rs m -94 -170 25 -321 341 
From Investments Rs m 14 5 10 7 9 
From Financial Activity Rs m -21 -33 -26 306 -344 
Net Cashflow Rs m -101 -198 9 -8 6 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 59.3%
Institution 0.0%
Non-Institution 40.8%
Total 100.0%
Free Float 40.8%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Village Chola Dist, Bulandshahar - 203203
E-MAIL complianceofficer_bibcol@yahoo.in WEB www.bibcol.com
TEL 05732-238758 / 238759 / 238760 / 238761 / 62 / 63 FAX 05732-238757 / 224801
SECTOR PHARMACEUTICALS GROUP PSU
TR AGENT MAS Services Ltd, T-34 2nd Floor, Okhla Industrial Area, Phase - II
YEAR OF INC: 1989 BSE CODE: 524663 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SYNCOM FORMULATIONS  SANOFI INDIA  LYKA LABS  VIVANZA BIOSCIENCES  SAMRAT PHARMA  

Compare BH.IMMUN&BIO With:   SYNCOM FORMULATIONS  SANOFI INDIA  LYKA LABS  VIVANZA BIOSCIENCES  SAMRAT PHARMA  




Today's Market

Sensex Ends Above 60,000-Mark, Nifty Tops 17,850; Asian Paints & Eicher Motors Climb 3%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock (Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield (Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC (Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

India's Most Trusted Corporate Group is... (Views On News)

Sep 11, 2021

We conducted a poll of 17 of the most popular corporate groups in India. With an overwhelming response from 5,274 participants, here is what we found.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BH.IMMUN&BIO

  • Track your investment in BH.IMMUN&BIO with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BH.IMMUN&BIO

BH.IMMUN&BIO 8-QTR ANALYSIS

COMPARE BH.IMMUN&BIO WITH

MARKET STATS